15 October 2023

Polpharma’s new kilo-scale development and production laboratory is up and running

Polpharma is the largest Polish manufacturer of active pharmaceutical ingredients (APIs), or active ingredients for the production of finished drug forms. They are available in more than 60 countries, including the largest markets: USA, TOP5EU, in Japan, Korea, Brazil, China and many others.

In 2021, Polpharma launched a comprehensive investment program for further development of active substances, which includes, among other things, the construction of a plant for the production of highly potent APIs. One of the milestones of the adopted strategy is the commissioning of a new kilo-scale development and production laboratory (“Kilo Lab”). Filled with the latest technology, the facility enables the production of the most advanced substances in Poland.

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.